FDA warns homeopathic company about illegal product claims

FDA warns homeopathic company about illegal product claims

(HealthDay)—Nutra Pharma Corp. has been warned about illegal marketing of unapproved homeopathic products with claims that they can treat addiction and chronic pain from serious conditions such as cancer, diabetes, shingles, and fibromyalgia, the U.S. Food and Drug Administration says.

A was issued to the company for the products Nyloxin Oral Spray, Nyloxin Topical Gel, Nyloxin Topical Roll-On, Nyloxin Topical Roll-On ES, Nyloxin Professional Size Pump Topical Gel, and Regular Strength Sample Pack. The names of the products may also confuse consumers because they are similar to the names of FDA-approved products, the agency said.

The FDA asked Nutra Pharma to respond within 15 working days and warned that failure to correct the violations may result in such as seizure and injunction.

"Health fraud scams like these are inexcusable. These patients deserve proven treatments not that can deter them from seeking otherwise effective care, and that can also contain ingredients or contaminations that can threaten their health," FDA Commissioner Scott Gottlieb, M.D., said in an agency news release. "We have great concern for the millions of Americans who live with or cancer, and for whom traditional treatment options have been exhausted, as well as those battling opioid addiction."

More information: More Information

Copyright © 2019 HealthDay. All rights reserved.

Citation: FDA warns homeopathic company about illegal product claims (2019, March 20) retrieved 29 May 2024 from https://medicalxpress.com/news/2019-03-fda-homeopathic-company-illegal-product.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

FDA warns 17 companies about illegal Alzheimer disease products


Feedback to editors